Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography.
about
Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET dataMolecular imaging in cancer treatment.Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment.PET imaging of early response to the tyrosine kinase inhibitor ZD4190.Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer.Heterogeneity in stabilization phenomena in FLT PET images of caninesFunctional imaging: what evidence is there for its utility in clinical trials of targeted therapies?Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer.(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors.Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.Recent advances in image-guided radiotherapy for head and neck carcinoma.Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone.Early monitoring antiangiogenesis treatment response of Sunitinib in U87MG Tumor Xenograft by (18)F-FLT MicroPET/CT imaging.PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials.Innovation in cancer imaging.Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.Predicting tumour response.FLT PET-CT in evaluation of treatment response.18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study.18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repairParametric mapping of [18F]fluoromisonidazole positron emission tomography using basis functions.The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture.Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer.Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis.Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer.
P2860
Q30275817-FC38D999-9CC5-4C4B-8770-565903F68C4AQ33750115-77062F27-56D7-402B-A20E-3C2335FEFE29Q33993075-90460EEB-1C35-4799-8E91-55064E68DA3BQ34207614-8110A0C1-125C-4DE8-95E0-CDB08F5C0C32Q34496670-3D6E06D2-9850-4ABD-8BA0-03A8332CCC65Q34744444-E0065A23-35BB-4CD3-9BF6-9AA2FA46B707Q34762148-F57B0CA1-4871-4659-ABB6-0ABDCAC0A039Q35249646-0BC75C51-7AA1-48D6-872F-96C3A3D119BAQ35537570-3A7F7CAE-7445-4F41-992E-3CC4857A6346Q35636166-FB1791A2-4840-4200-8028-5E66407AE198Q35879814-4FD6A6FF-222F-4C77-AD55-FF1C9D84622DQ36382036-34128172-C488-449A-9749-85054D5BA13AQ36563521-36883954-5CDB-45FB-AB7C-F8B09419A40CQ37314625-6AFDF953-A368-4E94-ACD5-D5FC28C35FE4Q37567466-4143988A-ED60-4813-972E-AC56D4F2CAA8Q37638896-2DB17C05-95B1-453F-932D-8F7785FC78E3Q37725493-190B0160-6AF3-44ED-8D42-1DAFC14737FBQ37832131-EDBAE951-D07E-4A61-AA8F-1BA76C318DF1Q37837982-1A44C5FD-3B7D-4DA3-BECA-A2388AE4F585Q38000044-CBC474FC-D647-4561-96BA-65545399B1EAQ38005915-9E9DA273-054D-457E-AA4B-E4AFD9167D3EQ38134094-DFD03E53-D9DC-4A3D-BC6E-E0F2A828B07DQ38141699-1E5146D1-53ED-4EFD-877B-0F374A26E04EQ38206772-AE1BB436-E8F6-4FB1-9E68-96493F18862DQ38421316-96F3BEAA-BB6F-4A11-8058-7E498B3DE392Q39662440-4A74FB0E-6BC5-4A3C-BFB1-956B462ACC74Q41448654-D43404D0-F097-4227-92F5-01BF6A496164Q41877778-2A3C72F8-9BC3-4935-8B0F-D103A41F4249Q41879155-76AB7C14-EEAD-454B-950C-F834D0520C99Q42098251-57F7B9F8-66C9-4498-9256-C604500572B1Q42419554-221C0F4E-6E28-4D97-8F92-21F9392F2CCDQ43491287-636544FA-42D9-4354-9D16-9747E56519DBQ48946602-43C2E3B0-9CFE-4D27-8259-0564EEB95FB1Q49836052-3478790A-0E1E-4074-ACDB-0EB0A428726BQ53161184-7A96B9FE-A4F8-43A3-9C6C-FC22A17F2127
P2860
Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Reproducibility of quantitativ ...... positron emission tomography.
@ast
Reproducibility of quantitativ ...... positron emission tomography.
@en
Reproducibility of quantitativ ...... positron emission tomography.
@nl
type
label
Reproducibility of quantitativ ...... positron emission tomography.
@ast
Reproducibility of quantitativ ...... positron emission tomography.
@en
Reproducibility of quantitativ ...... positron emission tomography.
@nl
prefLabel
Reproducibility of quantitativ ...... positron emission tomography.
@ast
Reproducibility of quantitativ ...... positron emission tomography.
@en
Reproducibility of quantitativ ...... positron emission tomography.
@nl
P2093
P50
P1476
Reproducibility of quantitativ ...... positron emission tomography.
@en
P2093
Adrianus J de Langen
Bianca Klabbers
Egbert F Smit
Marieke D Spreeuwenberg
Mark Lubberink
Otto S Hoekstra
Remco de Bree
P2860
P2888
P304
P356
10.1007/S00259-008-0960-5
P577
2008-10-18T00:00:00Z